Jeff W. Saranchuk

Dr. Ernest W. Ramsey Manitoba Prostate Center
Winnipeg, MB, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Treatment of High-Risk Biochemically Recurrent Prostate Cancer with Enzalutamide in Combination with Leuprolide: Secondary End Points from the EMBARK Trial: Erratum.

Treatment of High-Risk Biochemically Recurrent Prostate Cancer with Enzalutamide in Combination with Leuprolide: Secondary End Points from the EMBARK Trial: Erratum.

Journal: The Journal of urology

Published: July 09, 2026

Active surveillance for intermediate risk prostate cancer: the Manitoba Prostate Center experience.

Active surveillance for intermediate risk prostate cancer: the Manitoba Prostate Center experience.

Journal: BJU international

Published: May 20, 2026

Reply by Authors.

Reply by Authors.

Journal: The Journal of urology

Published: February 06, 2026

Reply by Authors.

Reply by Authors.

Journal: The Journal of urology

Published: February 06, 2026

Treatment of High-Risk Biochemically Recurrent Prostate Cancer With Enzalutamide in Combination With Leuprolide: Secondary End Points From the EMBARK Trial.

Treatment of High-Risk Biochemically Recurrent Prostate Cancer With Enzalutamide in Combination With Leuprolide: Secondary End Points From the EMBARK Trial.

Journal: The Journal of urology

Published: December 09, 2025

Metformin Active Surveillance Trial in Low-Risk Prostate Cancer.

Metformin Active Surveillance Trial in Low-Risk Prostate Cancer.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: October 30, 2025

The Association between Income Status and Treatment Selection for Prostate Cancer in a Universal Health Care System: A Population-Based Analysis.

The Association between Income Status and Treatment Selection for Prostate Cancer in a Universal Health Care System: A Population-Based Analysis.

Journal: The Journal of urology

Published: June 28, 2021

Two Cases of Sporadic Eosinophilic Solid and Cystic Renal Cell Carcinoma in Manitoba Population.

Two Cases of Sporadic Eosinophilic Solid and Cystic Renal Cell Carcinoma in Manitoba Population.

Journal: International journal of surgical pathology

Published: February 22, 2021

The Comparative Outcomes of Radical Prostatectomy versus Radiotherapy for Nonmetastatic Prostate Cancer: A Longitudinal, Population-Based Analysis.

The Comparative Outcomes of Radical Prostatectomy versus Radiotherapy for Nonmetastatic Prostate Cancer: A Longitudinal, Population-Based Analysis.

Journal: The Journal of urology

Published: February 19, 2020

Advancing Risk Assessment of Intermediate Risk Prostate Cancer Patients.

Advancing Risk Assessment of Intermediate Risk Prostate Cancer Patients.

Journal: Cancers

Published: May 06, 2019

Plasma microRNA signature is associated with risk stratification in prostate cancer patients.

Plasma microRNA signature is associated with risk stratification in prostate cancer patients.

Journal: International journal of cancer

Published: March 28, 2017

Filtration-based enrichment of circulating tumor cells from all prostate cancer risk groups.

Filtration-based enrichment of circulating tumor cells from all prostate cancer risk groups.

Journal: Urologic oncology

Published: July 15, 2016

Showing 1-12 of 14

Last Updated: 09/26/2026